These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Treatment
15 results:

  • 1. Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer.
    Dmello RS; Palmieri M; Thilakasiri PS; Doughty L; Nero TL; Poh AR; To SQ; Lee EF; Douglas Fairlie W; Mielke L; Parker MW; Poon IKH; Batlle E; Ernst M; Chand AL
    Cell Death Dis; 2024 Apr; 15(4):255. PubMed ID: 38600086
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway.
    Liu B; Zheng X; Li J; Yao P; Guo P; Liu W; Zhao G
    BMC Cancer; 2023 Nov; 23(1):1070. PubMed ID: 37932661
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mapping a Circular RNA-microRNA-mRNA-Signaling Regulatory Axis That Modulates Stemness Properties of cancer Stem Cell Populations in colorectal cancer Spheroid Cells.
    Rengganaten V; Huang CJ; Tsai PH; Wang ML; Yang YP; Lan YT; Fang WL; Soo S; Ong HT; Cheong SK; Choo KB; Chiou SH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114016
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinicopathological features and prognosis in patients with presacral recurrent rectal cancer].
    Wang C; Guo P; Yang XD; Xie QW; Yin MJ; Jiang KW; Liang B; Shen ZL; Shen K; Wang S; Ye YJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):461-465. PubMed ID: 32842425
    [No Abstract]    [Full Text] [Related]  

  • 5. Down-regulating IL-6/gp130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
    Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in cancer: Challenges and Opportunities.
    Kampan NC; Xiang SD; McNally OM; Stephens AN; Quinn MA; Plebanski M
    Curr Med Chem; 2018; 25(36):4785-4806. PubMed ID: 28707587
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Percutaneous management of pulmonary metastases arising from colorectal cancer; a systematic review.
    Lyons NJ; Pathak S; Daniels IR; Spiers A; Smart NJ
    Eur J Surg Oncol; 2015 Nov; 41(11):1447-55. PubMed ID: 26358568
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
    Taniguchi K; Karin M
    Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.
    Cross-Knorr S; Lu S; Perez K; Guevara S; Brilliant K; Pisano C; Quesenberry PJ; Resnick MB; Chatterjee D
    BMC Cancer; 2013 Oct; 13():463. PubMed ID: 24098947
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
    Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.
    Calon A; Espinet E; Palomo-Ponce S; Tauriello DV; Iglesias M; Céspedes MV; Sevillano M; Nadal C; Jung P; Zhang XH; Byrom D; Riera A; Rossell D; Mangues R; Massagué J; Sancho E; Batlle E
    Cancer Cell; 2012 Nov; 22(5):571-84. PubMed ID: 23153532
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Interleukin-6--a key regulator of colorectal cancer development.
    Waldner MJ; Foersch S; Neurath MF
    Int J Biol Sci; 2012; 8(9):1248-53. PubMed ID: 23136553
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease.
    Rose-John S; Mitsuyama K; Matsumoto S; Thaiss WM; Scheller J
    Curr Pharm Des; 2009; 15(18):2095-103. PubMed ID: 19519447
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
    Wei LH; Baumann H; Tracy E; Wang Y; Hutson A; Rose-John S; Henderson BW
    Br J Cancer; 2007 Dec; 97(11):1513-22. PubMed ID: 17987036
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
    Atreya R; Neurath MF
    Clin Rev Allergy Immunol; 2005 Jun; 28(3):187-96. PubMed ID: 16129903
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.